Cupron Inc., a developer of copper bioactive fibers for surgical masks and other uses, has raised $3 million, in a financing round led by Virginia Life Science Investments LLC (VSLI) and private investors.
Investor Dan Lustiger, former CFO of Shikun u'Binui Holdings Ltd. (TASE: SKBN) will replace Cupron CEO Jeffrey Gabbay, who founded the company.
Copper has well-known anti-bacteriological features. Cupron has developed a proprietary copper oxide compound, which it combines in a wide range of products, especially cloths. The company markets masks, sheets, eye covers, socks for diabetics, and sufferers of fungal infections, and gloves. Last August, the company obtained EU CE Mark certification for its Cupron Viral Deactivator, a Type IIR disposable patient/surgical mask.
The company was awarded a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation to support a global health research project conducted by Cupron Chief Medical Scientist Dr. Gadi Borkow, entitled "The Cupron Breastmilk Shield to Prevent HIV Transmission."
Published by Globes [online], Israel business news - www.globes-online.com - on January 19, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010